tirzepatide compound end date Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute Affordable Compounded Tirzepatide Injections -

Two patients on the 5 mg dose discontinued treatment

Choose Semaglutide (Wegovy) If: Best for people who: Want the longest safety track record (5 years) Have good insurance coverage for Wegovy specifically Prefer lowest discontinuation rate (6.9%) Are satisfied with 15% average weight loss Advantages: Most real-world data, proven track record since 2021 Disadvantages: Lowest efficacy (14.9%), highest cost ($1,349/month) Choose Tirzepatide (Zepbound) If: Best for people who: Want highest efficacy among available options (22.5%) Prefer best tolerability (31% nausea, lowest) Want better value (~$290/month cheaper) Want medication available today Advantages: Superior efficacy, best side effect profile, lower cost Disadvantages: Less long-term data than Semaglutide (3 years vs 5) Consider Waiting for Retatrutide If: Might make sense if you: Can wait until 2027-2028 without health consequences Want maximum weight loss (28.7%) Have tried both Semaglutide and Tirzepatide with insufficient results Have flexible health timeline Advantages: Highest efficacy (28.7%) Disadvantages: 2+ year wait, highest discontinuation (18.2%), no long-term data Realistic Recommendations For most people today: Choose Tirzepatide

Even without exercise, adequate protein maintains metabolic function and prevents the muscle loss that naturally occurs during calorie reduction

Both drug classes can affect appetite and eating patterns, though through different mechanisms

12 mg group: 24.1%

But there are some indirect reasons your B12 could drop while you are on it, and that is worth paying attention to